AstraZeneca Plc

Headquarters location: 15 Stanhope Gate London W1Y6LN Tel. 44-171-304-5000 Job offers, investor relations: www.astrazeneca.com Email: investor-relations@astrazeneca.com Stock:

AstraZeneca belongs to shareholder country     % source Investor AB Les Echos AstraZeneca owns subsidiary country     % source Astra (Pharma) 100 MedImmune, Inc 100 Les Echos Syngenta AG 39	Brands name items photo compare the prices Astrazeneca Ethishop Cambridge Antibody Technology Ethishop Crestor Ethishop Inderal Ethishop Iressa Ethishop Katana Ethishop Mission Ethishop Mopral Ethishop Novaldex Ethishop Prilosec Ethishop Pulmicort Ethishop Seroquel Ethishop Toprol XL Ethishop Xylocaine Ethishop Shop local, ethical and at the best price on Ethishop !
« ETHICAL » RATING OF ASTRAZENECA , group and subsidiaries [click on the images below or on help for more information] 10% Job: 10% of company's jobs cut since 1998 1 Environment: 1 major pollution(s) 3 Delinquency: 3 act(s) of financial or trade delinquency 1 Tax haven, secret bank account, shell companies: operates in 1 offshore financial center(s) 19 Sales: more than 19 billion(s) dollars/euros in annual sales 21 Net profit: more than 21 billion(s) dollars/euros in cumulated net profit since 1998 63 Top management: earns 63 times the median income in the United States (32000 US$/year) 5 Influence: 5 act(s) of direct corruption or lobbying 2 Advertising & marketing: 2 dubious practice(s) Full profile >>>
Relevance: business & market share year business source 2006 AstraZeneca is the world's fifth-largest pharmaceutical group. Les Echos World locations & Manufacturing country incentive : address & contact : production type source   Bangalore : R&D Les Echos Dublin : R&D Les Echos   Astra, MEXICO NAUCALPAN URBINA 15 PARQUE INDUSTRIAL & 5 3006906 : The map of tax haven, secret accounts and shell companies AstraZeneca is managed by year name photo position; compensation source 2006Schweitzer, Louis Chairman of the Board; attendance fee: 0.38 million Eu€; Capital 2004Schweitzer, Louis Director; Les Echos 2003Angelici, Bruno Executive Vice-President; 2003Barnevik, Percy N Chairman; 2003Buchanan, John Director; 2003Henney, Jane Director; 2003Hooper, Michele Director; 2003Jimenez, Joe Director; 2003McKillop, Tom Chief Executive Officer; 2003Mogren, Håkan Chairman; 2003Möller, Erna Director; 2003Ogilvie, Dame Bridget Director; 2003Symonds, Jonathan Chief Financial Officer; 2003Von der Heyden, Karl Director; 2003Wallenberg, Marcus Director; 1999Bonfield, Peter Director; Highest paid executives in 2007 Advertising & marketing year dubious practice : image source 2007 Disinformation: The medical representatives of AstraZeneca incite the doctors to prescribe inexium to replace Mopral, competed with by a generic drug. The Inexium however does not bring any additional therapeutic effectiveness but its refunding by the Social security cost 300 million euros in five years to the policy-holders.: UFC Que Ch. 2004 Arguable partnership: Don pour les victimes du tsunami:715 000 euros: value: Humanitaire; AFP Dubious practices in 2007

Made by year employees <> social impact : country source 2007 -3600 Internal restructuring: AstraZeneca toughens its reorganization plan and finally cuts 10% of its 2006 workforce. AstraZeneca will save more than 656 million euros a year from now to 2010.: L'usine no. 2007 -70 Internal restructuring: France Les Echos 2007 -3000 Internal restructuring: AstraZeneca cuts 4,6% of its workforce, in spite of 6 billion dollars net profit in 2006.: United States of America L'Expansio. 2002 58700 2001 54600 1998 34000 Layoff plans and labour conditions in 2007 Environmental impact year country : consequences source 2005 brand: Seroquel : Older patients with dementia who are given antipsychotic medicines are far more likely to die prematurely than those given placebos. Most died of heart-related problems like heart failure or infections like pneumonia (FDA) New York T. 1999 : Production, purchase or sale of genetically modified organisms which may cause an irreversible genetic pollution, a destruction of the biodiversity and health risks for the consumers. The Guardi. Pollutions in 2007 Influence year purpose : intermediary/lobby : institution source 2000 Limit the legal liability, no price control, no list of preferred drugs, hampers the approval and marketing of generic drugs, no drug imports, no limit to drug advertising… : Pharmaceutical Research and Manufacturers of America : : US government, congress, senate translate Washington. 2000 Lift the ban on bovine growth hormons, the moratorium on GMOs : EFPIA (European Federation of Pharmaceutical Industry Associations) : : European Commission translate EFPIA 1999 Market access and investment protection (through WTO, GATS), avoid social and environmental rules : ICC (International Chamber of Commerce) : : WTO, GATS translate Corporate . 1998 Regulation favorable to company's interests : Contribution to Candidate's Political Action Committee : amount: 125 thousand US$ : US President, Congress, Senate translate Center for. Influence in 2007 Financials year financial misdemeanor sales income buyback source 2006   6   billion US$ L'Expansio. 2005 Condamné par la Commission Européenne pour pratiques anticoncurrentielles. Le laboratoire a détourné des procédures administratives dans le but de protéger les ventes de son anti-ulcéreux vedette, le Losec (vendu en France sous le nom de Mopral),. A trompé plusieurs offices de brevets nationaux sur la date à laquelle il a reçu sa première autorisation de mise sur le marché, ce qui lui a permis d'obtenir une protection complémentaire dans certains pays. A détourné les règles et procédures appliquées par les agences nationales des médicaments, qui délivrent les autorisations de mise sur le marché. Il a en effet remplacé la présentation d'origine du Losec, en capsules, par des comprimés, en demandant à des agences nationales d'annuler les autorisations de mise sur le marché des premières. Ce qui a pu empêcher des importateurs d'obtenir des licences d'importation, faute d'autorisation de référence. Amende de 60 millions d'euros.     Les Echos 2005   0.6 million shares Cercle Fin. 2004 Guilty plea by AstraZeneca: collusion among drug companies and doctors to bill government health programs for free samples given as promotions     Bloomberg 2003   18.85 4.2   billion US$ Les Echos 2002   17.84 2.84   billion US$ 2001   16.48 2.97   billion US$ 2000   18.1 2.54   billion US$ 1999   18.45 1.14   billion US$ 1998   9.37 1.18   billion US$ 1996 Defrauded the US healthcare system: gived free samples of cancer drugs to doctors, who then billed Medicare for the full price.     BBC News Financial delinquency in 2007

Home > Companies: # A B C D E F G H I J K L M N O P Q R S T U V W X Y Z >

---

---

---

Further investigation

Good corporate practice? Pollution, layoff plan? Doubtful publicity or lobbying? Take part! Publish here :
Also announce a documentary, a book or an article or comment this company profile.
Goal: present the company activities, improve the ethical rating's accuracy, develop an network of observers.

Name (or ninckname)*		Email
Title*		Link to document online
Information*
Alert me of answers by email			* required field
Please copy the antispam code:

The 5 latest validated comments

Banco internacional investimentos   No Tax Haven - Saturday 21 June 2008 at 13h02

Banco internacional investimentos   Another offshore bank? - Saturday 21 June 2008 at 13h00

Banco internacional investimentos   Sustainable Bank - Saturday 21 June 2008 at 12h54

Amerada hess   Reverend - Thursday 19 June 2008 at 08h17

Anshan benxi steel group   Sgt. - Thursday 19 June 2008 at 02h04

All comments